Frost edit · Free shipping over $70 · Cool essentials
surmount 1 tirzepatide

surmount 1 tirzepatide cuts diabetes risk by 94% in SURMOUNT-1 trial A 3-year study of tirzepatide

SKU: 76117898007
4.0
USD27.02 USD64.02

Pay in 4 interest-free payments of $6.75 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 25 - Aug 30

Description

In SURPASS-2, a head-to-head in T2D patients, tirzepatide 15 mg produced 11.2 kg weight loss versus 5.7 kg on semaglutide 1 mg (the T2D dose at the time, not the 2.4 mg obesity dose)

surmount 1 tirzepatide cuts diabetes risk by 94% in SURMOUNT-1 trial A 3-year study of tirzepatide

Presented for research literature review only Guideri F et al

surmount 1 tirzepatide cuts diabetes risk by 94% in SURMOUNT-1 trial A 3-year study of tirzepatide

And if you have missed more than 2 consecutive weeks, contact your provider

surmount 1 tirzepatide cuts diabetes risk by 94% in SURMOUNT-1 trial A 3-year study of tirzepatide

Peng, W

surmount 1 tirzepatide cuts diabetes risk by 94% in SURMOUNT-1 trial A 3-year study of tirzepatide

Studies show: ~13% reduction in cardiovascular death Lower rates of heart attack and stroke Meaningful improvements in kidney outcomes Initial evidence suggests that these benefits extend beyond diabetic populations, further broadening the underwriting implications

surmount 1 tirzepatide cuts diabetes risk by 94% in SURMOUNT-1 trial A 3-year study of tirzepatide
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products